-

Organigram Announces Executive Change

MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces that Ray Gracewood, Senior Vice President of Marketing and Communications has left Organigram to pursue other interests.

Organigram would like to thank Mr. Gracewood for his many foundational contributions to the organization and wish him well in his future endeavors. “Ray is a pioneer in cannabis marketing. He has been instrumental in launching Organigram’s medical business and building out its adult-use recreational brand portfolio” said Greg Engel, Chief Executive Officer. During Mr. Gracewood’s tenure Organigram was the recipient of numerous industry awards including most recently the Lift Canadian Cannabis Awards: “Top High THC Oil” and Leafly’s Readers Choice Awards: “Top THC-Dominant Flower - La Strada”, “Top Pre-Roll - El Dorado”, “Top CBD Oil – Edison CBD”, “Top THC Oil – Edison Sativa”.

Julie Chamberlain has been promoted to Vice President of Marketing. Julie joined the Organigram team in August 2019 as the Senior Director of Brand. Julie is a seasoned manager, marketer and brand leader with over 12 years of international experience at L’Oréal including at its Parisienne head office as well as two years as Senior Brands Strategist at Irving Oil. At L’Oréal Ms. Chamberlain most recently served as General Manager for the NYX Professional Division. Julie has proven experience in building high performing teams in consumer packaged goods (CPG) focused on retail, indirect and e-commerce growth.

About Organigram Holdings Inc.:

Organigram Holdings Inc. is a NASDAQ and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company 's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

For more information about Organigram please visit www.Organigram.ca

Contacts

Investor Relations Enquiries:
Amy Schwalm
Vice President, Investor Relations
(416) 704-9057
Amy.Schwalm@organigram.ca

Media Enquiries:
Marlo Taylor
Gage Communications
mtaylor@gagecommunications.ca

Organigram Holdings Inc.

NASDAQ:OGI

Release Versions
$Cashtags

Contacts

Investor Relations Enquiries:
Amy Schwalm
Vice President, Investor Relations
(416) 704-9057
Amy.Schwalm@organigram.ca

Media Enquiries:
Marlo Taylor
Gage Communications
mtaylor@gagecommunications.ca

More News From Organigram Holdings Inc.

Organigram Reports Second Quarter Fiscal 2026 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the second quarter ended March 31, 2026 (“Q2 Fiscal 2026” or "Q2"). Q2 FISCAL 2026 HIGHLIGHTS Gross Revenue: $93.3 million (-9% year-over-year). Net Revenue: $59.8 million (-9% year-over-year). International Revenue: $6.1 million (0% year-over-year). Adjusted EBITDA2: $0.9 million (-82% year-over-year)....

Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2026 ended March 31, 2026, on Tuesday, May 12, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, May 12, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use t...

Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities

TORONTO & BERLIN--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) and Sanity Group GmbH (“Sanity” or “Sanity Group”) jointly announced the successful closing of Organigram’s previously announced acquisition (the “Acquisition”) of Sanity Group, pursuant to the terms of a share purchase agreement dated February 18, 2026 (the “Share Purchase Agreement”). In connection with closing of the Acquisition, a wholly owned subsidiary of the Company acquire...
Back to Newsroom